Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation (Q36438849)

14 August 2017

1 reference

title

Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation (English)

1 reference

14 August 2017

0 references

1 reference

coronary artery disease

1 reference

William C Stanley

1

1 reference

14 August 2017

Hani N Sabbah

series ordinal

2

1 reference

14 August 2017

publication date

1 December 2005

1 reference

14 August 2017

published in

Heart Failure Reviews

1 reference

14 August 2017

volume

10

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

275-279

1 reference

Regulation of fatty acid oxidation in the mammalian heart in health and disease

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-7542-4

Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-7542-4

Diabetes and the control of pyruvate dehydrogenase in rat heart mitochondria by concentration ratios of adenosine triphosphate/adenosine diphosphate, of reduced/oxidized nicotinamide-adenine dinucleotide and of acetyl-coenzyme A/coenzyme A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-7542-4

Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-7542-4

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-7542-4

Effect of nicotinic acid on myocardial metabolism in man at rest and during exercise

21 January 2018

1 reference

12 December 2020

Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia

1 reference

12 December 2020

Effects of acute hyperglycemia on myocardial glycolytic activity in humans

1 reference

12 December 2020

Myocardial lactate extraction: multi-determined metabolic function

1 reference

12 December 2020

Relation between work and phosphate metabolite in the in vivo paced mammalian heart

1 reference

12 December 2020

The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group

1 reference

12 December 2020

Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia

1 reference

12 December 2020

Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.

1 reference

12 December 2020

Metabolic fate of extracted glucose in normal human myocardium

1 reference

12 December 2020

Effect of trimetazidine on carnitine palmitoyltransferase-1 in the rat heart

1 reference

12 December 2020

Myocardial substrate metabolism in the normal and failing heart

1 reference

12 December 2020

Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart

1 reference

12 December 2020

Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina

1 reference

12 December 2020

Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation

1 reference

12 December 2020

Mechanism of action of oxfenicine on muscle metabolism

1 reference

12 December 2020

Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo

1 reference

12 December 2020

Acute hibernation decreases myocardial pyruvate carboxylation and citrate release

1 reference

12 December 2020

Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart

1 reference

12 December 2020

The metabolism of the heart

1 reference

12 December 2020

Partial fatty acid oxidation inhibitors for stable angina

1 reference

12 December 2020

Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective

1 reference

12 December 2020

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions

1 reference

12 December 2020

Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris

1 reference

12 December 2020

Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia

1 reference

12 December 2020

Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion

1 reference

12 December 2020

Effect of nicotinic acid on exogenous myocardial glucose utilization.

1 reference

12 December 2020

Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine

1 reference

12 December 2020

Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart

1 reference

12 December 2020

Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation

1 reference

12 December 2020

Partial inhibition of fatty acid oxidation increases regional contractile power and efficiency during demand-induced ischemia

1 reference

12 December 2020

10.1007/S10741-005-7542-4

Identifiers

DOI

1 reference

14 August 2017

1 reference